vimarsana.com

Latest Breaking News On - Digestive disease - Page 6 : vimarsana.com

'Provider recommendation critical' to colonoscopy uptake for non-Hispanic Black adults

WASHINGTON — Provider recommendation was a major influencer for colonoscopy screening for young adults at average risk for colorectal cancer, especially non-Hispanic Black patients, according to data presented at Digestive Disease Week. “Screening rates are low among Black and Native American individuals, which happen to be the groups that have the highest incidence and

Washington
United-states
Meharry-medical-college
Tennessee
American
Rebecca-ekeanyanwu
Byrobert-stott
Heather-biele
Bren-simon-gastroenterology-quality-improvement-program
Meharry-medical-college-in-nashville
David-geffen-school-of-medicine
Hispanic-black

'Promising' low-calorie, plant-based diet may improve inflammation, therapy response in UC

WASHINGTON — “Even at short intervals,” an intermittent low-calorie, plant-based diet may improve inflammation and response to medical therapy among patients with moderately to severely active ulcerative colitis, according to a presenter. “Diet plays a role in IBD inflammation but there are very few clinical trials that examine the impact of diet on UC and, to my

Washington
United-states
Miami
Florida
Heather-biele
Bymonica-stonehill
Colitis-center
Miami-miller-school
Digestive-disease
Digestive-disease-week
Simple-clinical-colitis-activity-index

Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis

- 70% of Patients Receiving Seladelpar 10mg Achieved the Clinically Meaningful Composite Endpoint and 37% Achieved ALP Normalization at 12 Months - - Reduction in Patient-Reported Pruritus was.

United-kingdom
Washington
United-states
Foster-city
California
Merdad-parsey
Gilead-sciences-in-liver-disease
Gilead-sciences-inc
Regulatory-agency
Nasdaq
Gilead-company
Exchange-commission

Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis – IT Business Net

Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Foster-city
California
United-states
Washington
Merdad-parsey
Exchange-commission
Cymabay-therapeutics-inc
Regulatory-agency
University-of-miami
European-medicines-agency
Gilead-sciences-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.